BIOMAT Database Logo BIOMAT Database Logo

Differential production of monoclonal antibodies to carbohydrate moiety or peptides moiety of glycoproteins by different routes of immunization. 1998

A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
Department of Legal Medicine, Wakayama Medical College, Japan.

The administration of ABO blood group active glycoproteins via the rear footpads of BALB/c mice with subsequent fusion of popliteal lymph node lymphocytes produced hybridomas differentially secreting antibodies to the peptide moiety of antigens. On the other hand, conventional intraperitoneal immunization of the same antigens and intraperitoneal boost followed by splenic lymphocyte fusion produced hybridomas differentially secreting antibodies to the carbohydrate moiety of antigens. Similar results were obtained in the production of monoclonal antibodies to erythrocyte membranes. Almost all hybridomas obtained by rear foodpad immunization secreted antibodies to the peptide moiety of erythrocyte membrane proteins, and those obtained by intraperitoneal immunization secreted antibodies to both peptide and carbohydrate moieties of erythrocyte membrane components. These results suggest the possibility of differential production of monoclonal antibodies to the carbohydrate moiety and the peptide moiety of some glycoproteins by different immunization routes.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002241 Carbohydrates A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrate
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
Production of monoclonal antibodies directed against carbohydrate moieties of cell surface glycoproteins.
October 1988, Japanese journal of cancer research : Gann,
A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
Production of monoclonal antibodies by genetic immunization.
April 1994, BioTechniques,
A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
Production of antibodies by single DNA immunization: comparison of various immunization routes.
August 2002, Hybridoma and hybridomics,
A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
Monoclonal antibodies to thymidine glycol generated by different immunization techniques.
April 1997, Hybridoma,
A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants.
February 1985, Cancer research,
A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
ANTIBODY RESPONSE TO IMMUNIZATION BY DIFFERENT ROUTES.
August 1964, Science (New York, N.Y.),
A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
Production and characterization of monoclonal antibodies to anti-human chorionic somatomammotropin by immunization with two free synthetic peptides.
November 1985, Molecular immunology,
A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
Peptides and monoclonal antibodies which bind to platelet glycoproteins IIb and/or IIIa inhibit clot retraction.
January 1988, Thrombosis research,
A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
Production of anti-dengue NS1 monoclonal antibodies by DNA immunization.
April 2003, Journal of virological methods,
A Kimura, and R Nakashima, and H Inoue, and S Yasuda, and E Ikemoto, and K Nishimoto, and T Tsuji
[Production of monoclonal antibodies against tooth germs of hamster or rat by in vitro immunization].
December 1989, Fukuoka igaku zasshi = Hukuoka acta medica,
Copied contents to your clipboard!